Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Heene

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Thrombosis Research|October 1, 1992
Heparin Study in Internal Medicine (HESIM): design and preliminary resultsJ Harenberg, P Roebruck, G Stehle, et al.
Zeitschrift Fur Kardiologie|March 1, 1985
[Tachycardias caused by double ventricular responses and unusual atrioventrio-ventricular relations in linear dissociation of the AV node]J Buss, B Stegaru, J Kraatz, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosisJ Harenberg, G Stehle, M Blauth, et al.
Thrombosis Research|October 9, 1999
Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitorG Huhle, C Abletshauser, N Mayer, et al.
Zeitschrift Fur Kardiologie|August 1, 1996
[Value of dipyridamole-atropine stress echocardiography for detection of patients with restenosis after PTCA]A Scherhag, S Pfleger, A Schreckenberger, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1994
Semisynthesis and analysis of lipophilically modified unfractionated and low molecular mass heparinsR Malsch, J Harenberg, M Guerrini, et al.
Hepatology (Baltimore, Md.)|May 1, 1988
Ventricular function in cirrhosis and portasystemic shunt: a two-dimensional echocardiographic studyH Keller, V Bezjak, B Stegaru, et al.
Thrombosis Research|August 30, 2000
A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot studyG Huhle, U Hoffmann, I Hoffmann, et al.
British Journal of Haematology|August 12, 1999
Immunologic response to recombinant hirudin in HIT type II patients during long-term treatmentG Huhle, U Hoffmann, X Song, et al.
Thrombosis and Haemostasis|May 1, 1997
Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogenC E Dempfle, S A Pfitzner, D Schott, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Thrombosis Research|October 1, 1992
Heparin Study in Internal Medicine (HESIM): design and preliminary resultsJ Harenberg, P Roebruck, G Stehle, et al.
Zeitschrift Fur Kardiologie|March 1, 1985
[Tachycardias caused by double ventricular responses and unusual atrioventrio-ventricular relations in linear dissociation of the AV node]J Buss, B Stegaru, J Kraatz, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosisJ Harenberg, G Stehle, M Blauth, et al.
Thrombosis Research|October 9, 1999
Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitorG Huhle, C Abletshauser, N Mayer, et al.
Zeitschrift Fur Kardiologie|August 1, 1996
[Value of dipyridamole-atropine stress echocardiography for detection of patients with restenosis after PTCA]A Scherhag, S Pfleger, A Schreckenberger, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1994
Semisynthesis and analysis of lipophilically modified unfractionated and low molecular mass heparinsR Malsch, J Harenberg, M Guerrini, et al.
Hepatology (Baltimore, Md.)|May 1, 1988
Ventricular function in cirrhosis and portasystemic shunt: a two-dimensional echocardiographic studyH Keller, V Bezjak, B Stegaru, et al.
Thrombosis Research|August 30, 2000
A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot studyG Huhle, U Hoffmann, I Hoffmann, et al.
British Journal of Haematology|August 12, 1999
Immunologic response to recombinant hirudin in HIT type II patients during long-term treatmentG Huhle, U Hoffmann, X Song, et al.
Thrombosis and Haemostasis|May 1, 1997
Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogenC E Dempfle, S A Pfitzner, D Schott, et al.
Pageof 15